Back to search

Article

Repurposing drugs for the prevention of vascular dementia: Evidence from drug target Mendelian randomization

2025-04-11

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Importance</h4> Vascular dementia (VaD) is a devastating cerebrovascular disease with no disease-modifying treatments available. Repurposing existing drugs for VaD risk factors could have an important clinical impact. <h4>Objective</h4> To determine whether lipid-lowering, anti-hypertensive, or anti-inflammatory drug targets affect the risk of vascular dementia using Mendelian randomization....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
472ba50f-c1ce-500a-8720-4e4eea7d2887
DOI
10.1101/2025.04.11.25325641
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposing drugs for the prevention of vascular dementia: Evidence from drug target Mendelian randomizationDOI 10.1101/2025.04.11.25325641
Causes and consequences of vascular dementia across the life course: Evidence from a UK Biobank phenome-wide and Mendelian randomization studySemantic proximity
Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian Randomization studySemantic proximity
Mendelian Randomization in Stroke: A Powerful Approach to Causal Inference and Drug Target ValidationSemantic proximity
Genetically proxied PDE5 inhibition and risk of dementia: a drug target Mendelian randomisation studySemantic proximity
Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.Semantic proximity
Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort studySemantic proximity
Low-Density Lipoprotein Cholesterol and Dementia Risk: Integrating Mendelian Randomization and Target Trial Emulation Within the Heart–Brain AxisSemantic proximity
Causal Effects of the Plasma Proteome on Vascular Dementia Risk: A Mendelian Randomization Study with Experimental ValidationSemantic proximity
Leveraging Mendelian randomization to inform drug discovery and development for ischemic strokeSemantic proximity
Causal insights of modifiable cardiovascular risk factors for dementia risk - potential for efficient prevention and improved brain health.Semantic proximity
Genetic downregulation of interleukin-6 signaling and arteriolosclerotic cerebral small vessel disease: a drug target Mendelian randomization analysisSemantic proximity
LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization StudySemantic proximity
Select a neighboring publication to make it the new centre.